Steven de Jong
机构: Professor of Preclinical and Translational Oncology, University Medical Center Groningen
主页: rug.nl
每年引用次数
引用次数
引用: 15,886
H-指数: 66
I10-指数 : 170
出版物: 349
Leren is ondernemen – Draagvlak voor een vignet Leren Ondernemen?
Sijbren de Jong , Jasper Bakker
1
2006
Utility of circulating biomarkers of cell death in disseminated testicular cancer patients treated with standard platinum-based chemotherapy
Jourik A. Gietema , Esther C. de Haas , Alessandra Di Pietro , Caroline Dive
Molecular Cancer Therapeutics 6 ( 12)
1
2007
Correspondence re: C. G. Ferreira et al., Apoptosis: Target of Cancer Therapy. Clin. Cancer Res., 8: 2024–2034, 2002.
Jourik A. Gietema , E. G. E. de Vries , Steven de Jong , Marjolijn de Hooge
Clinical Cancer Research 9 ( 2) 912 -912
28
2003
Pharmacomethylomics: methylation profiling applied to drug resistance models
Pauline de Graef , Geert Trooskens , Steven de Jong , Ate van der Zee
Clinical Cancer Research 12
2006
Expression of TRAIL and TRAIL death receptors in stage III non-small cell lung cancer tumors.
Wim Timens , Harry J M Groen , H Marike Boezen , Elisabeth G E de Vries
Clinical Cancer Research 9 ( 9) 3397 -3405
119
2003
Inhibition of IGF-1R-dependent PI3K activation sensitizes colon cancer cells specifically to DR5-mediated apoptosis but not to rhTRAIL
Janet H. Stegehuis , Elisabeth G. E. de Vries , Bodvael Pennarun , Steven de Jong
Cellular Oncology 33 ( 3) 229 -244
10
2010
Expression of proteins correlated with the unique cisplatin-sensitivity of testicular cancer
Ege deVries , NH Mulder , Trude de Graaf , Steven de Jong
Anticancer Research 17 369 -375
10
1997
Cell biological aspects of drug-resistance in human small cell lung carcinoma cells
Steven de Jong
s.n.
1991
Dual mTORC1/2 inhibition sensitizes testicular cancer models to cisplatin treatment
Ximena Rosas-Plaza , Gerda de Vries , Gert Jan Meersma , Albert J.H. Suurmeijer
Molecular Cancer Therapeutics 19 ( 2) 590 -601
4
2020
DNA hypermethylation biomarkers to predict response to cisplatin treatment, radiotherapy or chemoradiation: the present state of art.
Frank Roossink , Steven de Jong , G. Bea A. Wisman , Ate G. J. van der Zee
Cellular Oncology 35 ( 4) 231 -241
21
2012
Prognostic Significance of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand and Its Receptors in Adjuvantly Treated Stage III Colon Cancer Patients
Caroline M. van Geelen , Jantine L. Westra , Elisabeth G. de Vries , Wytske Boersma-van Ek
Journal of Clinical Oncology 24 ( 31) 4998 -5004
62
2006
Pro- and anti-apoptotic effects of p53 in cisplatin-treated human testicular cancer are cell context-dependent
Alessandra di Pietro , Roelof Koster , Wytske Boersma-van Eck , Wendy A. Dam
Cell Cycle 11 ( 24) 4552 -4562
23
2012
Proteasome inhibitor MG132 sensitizes HPV-positive human cervical cancer cells to rhTRAIL-induced apoptosis.
Brigitte M.T. Hougardy , John H. Maduro , Ate G.J. van der Zee , Derk Jan A. de Groot
International Journal of Cancer 118 ( 8) 1892 -1900
53
2006
Playing the DISC: Turning on TRAIL death receptor-mediated apoptosis in cancer
Bodvaël Pennarun , Annemieke Meijer , Elisabeth G.E. de Vries , Jan H. Kleibeuker
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1805 ( 2) 123 -140
222
2010
ARID1A mutant ovarian clear cell carcinoma: A clear target for synthetic lethal strategies.
Joseph J. Caumanns , G. Bea A. Wisman , Katrien Berns , Ate G.J. van der Zee
Biochimica et Biophysica Acta 1870 ( 2) 176 -184
67
2018
Targeting Trail Towards the Clinic
Devalingam Mahalingam , Corina N.A.M. Oldenhuis , Eva Szegezdi , Francis J. Giles
Current Drug Targets 12 ( 14) 2079 -2090
22
2011
Low p21Waf1/Cip1 protein level sensitizes testicular germ cell tumor cells to Fas-mediated apoptosis
Diana C J Spierings , Elisabeth G E de Vries , Alja J Stel , Nelina te Rietstap
Oncogene 23 ( 28) 4862 -4872
41
2004
Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer.
Tushar Tomar , Nicolette G. Alkema , Leroy Schreuder , Gert Jan Meersma
BMC Medicine 15 ( 1) 116
22
2017
Avenues to molecular imaging of dying cells: Focus on cancer
Anna A. Rybczynska , Hendrikus H. Boersma , Steven de Jong , Jourik A. Gietema
Medicinal Research Reviews 38 ( 6) 1713 -1768
15
2018
Translating TRAIL-receptor targeting agents to the clinic
Martha W. den Hollander , Jourik A. Gietema , Steven de Jong , Annemiek M.E. Walenkamp
Cancer Letters 332 ( 2) 194 -201
60
2013